Procurement Trends of Flea & Tick Treatments For Dogs in the USA

Procurement trends of flea & tick treatments for dogs in the USA 2022

Introduction:

In the United States, a disease caused by fleas and ticks has risen many folds in recent years and the consequent requirement of providing sufficient protection has increased in response. When it comes to treatment options, there is a plethora of flea and tick products available for dogs in different forms such as oral pills, topical (spot-on) solution, spray, collar, shampoo, and powder.

Veterinarians in the USA prescribe one/or more of those depending on the animal’s nature to safeguard the four-legged animals, but what do dog owners prefer and what are the buying trends for flea and tick treatments in the country? Let’s find out.

Favorable Brands

The majority of the veterinary medicine market in the USA is captured by a few key players. Frontline Plus (Fipronil & s.methoprene combination) from Boehringer Ingelheim (Merial) and Advantix (Imidacloprid and permethrin) from Bayer are noted to be very popular topical treatments among dog owners in the USA.

Among oral flea and tick treatments, Comfortis (Spinosad) from Elanco, Bravecto (Fluralaner) by Merck, Nexgard (Afoxolaner) from Boehringer Ingelheim (Merial) are the most frequently bought products across all states. Revolution (Selamectin) from Zoetis is noticeably the preferred all-in-one brand.

 

Check below the list of frequently bought flea and tick treatments with their manufacturers in the USA:

Flea-tick -treatment- purchases-in-the USA-Data-Table-CVE

 

Spot-On, Oral, or Collar

Flea and tick treatments and preventions hold the major share of customer spending on pet medications. A report suggests that approximately 70% of dog owners buy any type (oral, liquid, collar, spray) of flea & tick products. However, people living in remote locations favored topical (liquid) treatments, whereas dog owners of metropolitan cities choose to go with oral flea & tick therapies. It also reported that dog owners who used collars, about 35% of them used spot-on treatments too and roughly 20% also used oral flea and tick protections alongside.

 

Buy more types (oral, liquid, collar, spray) of flea & tick products

 

Preferred Frequency

Lack of knowledge among pet owners plays an important role in the selection of parasitic protection. A recent consumer study revealed that there are knowledge gaps among dog owners in relation to the recognition of various organisms and the necessity of continuously safeguarding their animal companion against them.

It reported that almost one-third of dog owners (33%) confirmed that they do not give their dog flea/tick treatments regularly and only buy the protective treatments when the infestation rate is visibly significant or when there’s a pest attack. About three-quarters (74%) of dog lovers don’t research flea & tick products, and only 40% of pet parents said that they treat their canine friend year-round.

 

Read More: 

Keep Your Pets Flea And Tick Free || Spot-on, Chews, Collars, and Spray

 

Coverage Per Year

The introduction of Fluralaner was a breakthrough event in veterinary medicine that enabled dog parents to reduce the frequency of administration of flea & tick treatments. A study was carried out to investigate flea and tick product buying trends in the USA. The veterinarians recommended year-round treatment coverage to participant dog owners.

The study reported that dog owners who bought Fluralaner to protect their dogs against fleas and ticks were buying a sufficient number of doses to protect their animals for approximately 6.0-6.3 months annually, whereas the dog owners who used other monthly antiparasitic therapies (Afoxolaner, Fipronil, Spinosad, Imidacloprid, Sarolaner) were reported to provide coverage for 4.2-4.5 months per year. The study concluded that with longer-acting flea/tick treatments, dog owners were better able to follow veterinary guidelines, however, they still fell short of the standard recommendations.

 

Conclusion

The year 2021 was quite a year for the veterinary pharmaceutical industry. A notable increase was observed in flea and tick-borne disease; consequently, procurement of flea and tick preventatives and treatments was on the rise too. Correspondingly, the commencing year 2022 is likely to see similar trends both in disease prevalence as well as in acquiring remedial agents.

 

Explore our pet shop online to get the best flea tick products